Login
$NGNE
$26.99 +$3.45 (14.66%) Close

Ownership

13F as of Q2 2026 · 20.0M shares outstanding

Who owns NGNE?

By type of holder
Institutions 86.5% Insiders 13.5% Everyone else 0.0%
Concentration Top 10 holders own 61.2%
Samsara Biocapital, LLC 8.6% · Casdin Capital, LLC 7.7%
Institutional ownership
86.5%
+1.7 pts vs last qtr
Institutional holders
111
+15 vs last qtr
Net shares bought
+342.6K
by institutions in Q2 2026
New / sold out
21 / 6
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • Franklin Resources Inc NEW +204.3K
  • Point72 Asset Management, L.P. NEW +141.9K

Sign up to see all 5.

Biggest sellers in Q2 2026
  • ArrowMark Colorado Holdings LLC −182.3K
  • Millennium Management LLC −162.1K

Sign up to see all 5.

Who is planning to sell?

Notices of proposed sale, last 12 months
$757K
3 notices from 2 people
Shares covered
30.8K
0.15% of the company
Arranged in advance
100%
of the value is under a 10b5-1 plan
Under a 10b5-1 plan No plan
$0$208.4K$416.7KNovDecJanFeb 2026: $188.9K under a 10b5-1 planFebMar 2026: $151.6K under a 10b5-1 planMarAprMay 2026: $416.7K under a 10b5-1 planMayJunJulAugSepOct
Largest proposed sellers
  • Christine Cvijic Officer 10b5-1 $606K
  • Stuart Cobb Officer 10b5-1 $152K
Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2024–FY2025
+21.4%
+21.40% a year
Each share's claim on the business
−17.6%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
— vs $22.5M
over 2 fiscal years
Diluted shares, split-adjusted
17.0M19.3M21.5M2024: 17.6M shares'242025: 21.3M shares'25
Buybacks Stock-based comp
$0$7.1M$14.2M2024 buybacks: $02024 stock comp: $8.3M'242025 buybacks: $02025 stock comp: $14.2M'25

How patient are the owners?

Institutional shares by how long they've been held
5+ years0% 3–5 years0% 1–3 years83% Under 1 year17%
Quarterly turnover
6.9%
of institutional shares changed hands
Top 10 managers, median time held
2.5 years

Super Investors

Investment managers reporting NGNE on Form 13F
SB
Samsara Biocapital, LLC
Shares
1.7M
% of company
8.58%
Change vs last qtr
Unchanged
Held since
2023
CC
Casdin Capital, LLC
Shares
1.5M
% of company
7.72%
Change vs last qtr
+125.0K (+8.8%)
Held since
2023

28 more super investors behind a free account

See every manager holding Neurogene Inc., how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting NGNE on Form N-PORT; together they hold 12.4% of the company
VT
Position value
$12.5M
% of company
1.99%
% of the fund
0.00%
As of
June 30, 2026
IR
iShares Trust
Position value
$9.32M
% of company
1.48%
% of the fund
0.01%
As of
June 30, 2026

23 more funds behind a free account

See every fund holding Neurogene Inc. and how much of the fund the position is.

Sign up free

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
MR
McMinn Rachel
Insider
Shares
1.3M
% of company
6.72%
Change vs last qtr
—
Held since
—
CC
Cvijic Christine Mikail
Insider
Shares
84.0K
% of company
0.42%
Change vs last qtr
—
Held since
—

2 more holders behind a free account

See every insider and 5%+ holder of Neurogene Inc..

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support